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Study Objectives: This paper explores the relationship between body mass index 
(BMI) and health-related quality of life (HRQoL), measured using EQ-5D, for men 
and women within a national population sample.  
 
Methods:  Data were taken from the 1996 Health Survey for England, an annual 
survey commissioned by the UK Department of Health.  HRQoL was measured using 
EQ-5D.  Informants’ BMI was calculated from height and weight measurements 
collected by trained nurses.  Details of any long-standing illness were also collected.  
Complete data was available for 11,783 cases aged 18 years or more.  
 
Main  Results: There were significant differences in EQ-5D by BMI category, 
although the nature of the relationship between EQ-5D and BMI differed by gender.  
For women, significant differences in EQ-5Dindex could be observed for each BMI 
category, which was independent of age and the presence of long-standing illness.  
For men, being classified within the obese BMI range was associated with poor EQ-
5Dindex  score, although this relationship disappeared after accounting for age and 
long-standing illness.  The EQ-5D  pain and mobility dimensions showed the greatest 
change in reported problems with increasing BMI.   Analysis showed little relationship 
between BMI and the EQ-5D anxiety/depression dimension. 
 
Discussion:  Most of the apparent relationship between BMI and HRQoL could be 
accounted for by age and the presence of long-standing illness.  However women’s 
HRQoL did appear to be sensitive to their weight.  Further investigation of the nature 
of the gender differences in the relationship between BMI and HRQoL would be 
useful. 
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Overweight and obesity is recognised as a rapidly growing threat to the health of 
populations in developed countries. The prevalence of obesity is between 10-25% in 
Western industrialised countries and is becoming a growing problem in other areas of 
the world [1].  Latest figures for the UK indicate that 19% of adults are obese [2] and 
it has been predicted that by 2005 over one fifth of men and about a quarter of 
women will be obese [3]. 
  
Overweight and obesity are associated with an increased risk of mortality at all ages 
and are recognised as a major determinant of many non-communicable diseases 
including type 2 diabetes (in particular), cardiovascular disease, hypertension, gall 
bladder disease, several types of cancers and degenerative joint disease [4-12].  In 
addition they are also associated with a significant degree of poor mental health [13, 
14].  Individuals with a BMI that is lower than that considered the desirable range (i.e. 
< 21-25kg/m
2) are also at increased risk of poor health, although most of the excess 
morbidity suffered by this group has been attributed to smoking and pre-existing 
disease [15].  
 
There is some evidence that having a BMI that is classified as overweight or obese  
(i.e. over 25kg/m
2) has a greater impact on the risk of disease for women than for 
men [12].  Among women, obesity is the third most important predictor of 
cardiovascular disease after age and blood pressure [4], while obese women are 
more likely to die of diabetes than overweight men [16].  An American Cancer 
Society report found that the mortality ratio for all cancers was 1.33 for obese men 
and 1.55 for obese women [17].  Obesity has also been associated with problems 
with fertility, pregnancy and childbirth [18].     
 
Compared to the extensive body of research on the relationship between obesity and 
mental and physical disease there has been relatively little work on the relationship 
between obesity and health-related quality of life (HRQoL), although in recent years 
the number of studies has been steadily increasing.  A number of measures have 
specifically been developed to examine the effect of weight on HRQoL [19, 20, 21].   
However, the majority of work in this area has tended to use the SF-36 [22] as the 
measure of HRQoL. 
 
Increasing weight and obesity has been shown to have an impact on the physical 
aspects of HRQoL such as role functioning, mobility and bodily pain.  Two studies of 
the general population have shown that individuals with a BMI of more than 30kg/m
2 
have significantly poor health on those dimensions of the SF-36 related to physical 
health and functioning [20, 23].  Obese individuals have also been shown to be more 
likely to rate their overall health as poor, to report more limitations on their functional 
health and report significantly higher levels of pain compared to the general 
population [24, 25].  Weight gain has been also associated, amongst women, with 
poorer HRQoL in terms of physical functioning, vitality and pain, while weight loss 
was associated with improved scores in the same areas [26].    
 
Although an association between overweight and obesity and poor mental wellbeing 
is frequently claimed, the research evidence tends to be mixed.  Studies that have 
found a relationship have tended to comprise samples of patients receiving treatment 
for obesity [13, 19, 26, 27].  In contrast, studies of the general population have shown 
little or no relationship between increased weight and poor emotional or social well 
being [20, 23].  It has been suggested that obesity is associated with poor emotional 





there do appear to be gender differences in the impact of weight on psychological 
health. Increased weight has been reported to have a greater impact on self-esteem 
and sexual life for women than for men [19], and increasing body weight has been 
associated with greater body dissatisfaction and lower self-esteem among women 
than men [29].  The existence of gender differences in the relationship between 
weight, body image and self-esteem are also well established [30, 31].  
 
HRQoL data is playing an increasingly important role in the evaluation of treatments 
for chronic disease states such as obesity.  Economic evaluation and cost utility 
analysis in particular rely on HRQoL data as a quality adjustment index when 
computing QALYs.  However, the relationship between HRQoL and BMI is still not 
fully understood.  This paper explores the relationship between BMI and EQ-5D, a 
widely used generic measure of HRQoL, in a British population sample.  It has two 
aims: firstly to determine the extent to which EQ-5D discriminates between 
individuals according to their BMI; and secondly to explore the extent to which this 




The Health Survey for England (HSE) is an annual large scale survey commissioned 
by the UK Department of Health and covers a representative sample of the 
population of England aged two years or more living in private households. The EQ-
5D was included in the 1996 survey and the data presented in the following report is 
taken from that year, during which survey interviews were obtained with 15,924 
adults aged 18 years or more [32]. 
 
2.2 EQ-5D 
EQ-5D was designed as a general-purpose instrument for use in clinical and 
economic studies as well as for monitoring population health status [33]. EQ-5D 
measures a person’s health in terms of their responses on five dimension questions 
(mobility, self-care, usual activities, pain or discomfort and anxiety or depression) and 
their self- rating of their health (from worst imaginable to best imaginable) on a visual 
analogue scale.  EQ-5D allows for an individual’s health status to be expressed in 
three ways: as a health profile of their responses on the five dimensions, as a single 
weighted summary score (EQ-5Dindex) and as a score on the visual analogue scale 
(EQ-5Dvas).   
 
Informants in the 1996 HSE were classified into one of the 243 hypothetical health 
states defined by EQ-5D, and assigned the appropriate weighted health state index 
score (EQ-5Dindex). Four hundred and thirty-four informants (3%) were excluded from 
the analysis because a value for EQ-5Dindex could not be computed.  Informants in 
the 1996 HSE survey were not required to complete the EQ-5D visual analogue 







Trained nurses recorded informant’s height and weight.  The data collection 
procedures are documented in detail elsewhere [34]. Respondents were categorised 
into three and five category BMI classifications as follows: three categories  <26kg/m
2 
desirable range; 26-30kg/m
2 overweight range; >30kg/m
2 obese range; five 
categories  <21kg/m
2 underweight range; 21-25kg/m
2 desirable range; 26-30kg/m
2 
overweight range; 31-39kg/m
2 obese range; >39kg/m
2 morbidly obese range. 
BMI could not be calculated for 3876 (24%) informants.  
  
2.4 Long-standing  illness 
Informants were asked to give details about any long-standing illness, disability or 
infirmity that had troubled them over a period of time.  A maximum of six conditions 
was recorded. 
 
2.5 Statistical  analysis 
4,141 cases (26%) with missing EQ-5D or BMI data were excluded leaving a sample 
size of 11,783.  Data were analysed separately for men and women.  ANOVA was 
used to test for differences in EQ-5D index score and reported problems on each 
dimension by BMI category.  The relationship between BMI and EQ-5D weighted 
health state index score (EQ-5Dindex) was also modelled using ordinary least squares 
regression.  EQ-5Dindex was the dependent variable; age group, BMI category and 
number of long-standing illnesses were the independent variables.   Age group was 
defined as a 7 category variable (18-24 years, 25-34 years, 35-44 years, 45-54 
years, 55-64 years, 65-74 years, 75+ years); BMI was defined as a 3 or 5 category 
variable and long-standing illness as a 5 category variable (no long-standing illness, 
1 long-standing illness, 2 long-standing illnesses, 3 long-standing illnesses, 4+ long-
standing illnesses).  The relationship between BMI category and likelihood or 
reporting problems on each of the EQ-5D dimensions was explored using 
multivariate analysis of variance (MANOVA), controlling for age and number of 
comorbidities.  EQ-5D dimension responses were recoded as dichotomous variables 
indicating no problems (0) and some problems (1).  Tukey tests were used to 
determine any significant group means post hoc. 
 
3. Results 
3.1 Sample  characteristics 
54% of the sample was female, the median age was 46 years (age range 18-97 
years).   In terms of age and sex there were no significant differences between the 
sample and the HSE 1996 adult sample as a whole. Just over two fifths of the 
sample reported having a long-standing illness.  The mean BMI for men was 
26.6kg/m
2 (S.D. 4.05) and for women 26.3kg/m
2 (S.D. 5.04).  For both men and 
women, BMI gradually increased with age to peak at age 55-64 years. There was an 
increasing prevalence of long-standing illness with increasing BMI.  Slightly more 
than a third (38%) percent of men and women with a BMI in the desirable range 
reported at least one long-standing illness compared to around half (49% of men and 
55% of women) with a BMI in the obese range.   





3.2  EQ-5D and BMI 
Table 1 shows the proportion reporting problems on each of the EQ-5D dimensions 
by BMI category for men and women.   There were significant differences in the 
proportion of reported problems by BMI category across all the dimensions, except 
anxiety/depression. The proportion reporting problems on all dimensions increased 
as BMI increased above the desirable range. The pain/discomfort and mobility 
dimensions tended to show the greatest increase in the proportion of reported 
problems and the anxiety/depression dimension showed the least increase. 
Respondents classified as within the underweight BMI range also tended to report 
more problems, than those in the desirable range.  
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Some  14.0  12.7  15.8 24.0 23.1  15.8   
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Some  15.8  13.0  14.6 17.8 19.2  14.6   
















Some  23.7  28.3  32.9 36.5 19.2  31.2   
















some  20  18.1  17.9 18.5 26.9  18.2   
severe  2.3  1.7  1.3 1.9 --  1.6   
N  215 2066  2356  779  26  5442   

















Some  15.8  11.6  20.7 31.0 38.3  18.5   
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Some  16.5  13.2  19.0 22.6 30.4  17.1   
















Some  28.1  30.3  38.0 42.5 45.2  34.8   
















Some  27.9  22  23.6 24.0 27.8  23.4   
Severe  2.5  1.4  2.1 2.4 0.9  1.9   






Table 2 presents mean EQ-5Dindex score by BMI and age group for men and women. 
For men, BMI appears to have little relationship with EQ-5Dindex score.  In contrast for 
women aged 35 years or more, there was a significant relationship between 
increasing BMI and decreasing EQ-5Dindex score. 
 
Table 2:  Mean (standard deviation) EQ-5Dindex score by BMI age group and sex 
BMI <21  kg/m
2 21-25  kg/m
2 26-30  kg/m
2 31-39  kg/m
2 >39  kg/m
2 Sig.  of 
F test 




































































































0.88  (0.22) 
26 
 
Sig. of F 
test 
0.004 0.000  0.000 0.000 0.735   









































































































Sig. of F 
test 
0.000 0.000  0.000 0.000 0.000   
 
3.3  Modelling the relationship between EQ-5Dindex and BMI 
BMI category and age group were entered into an OLS regression with EQ-5Dindex as 
the dependent variable (table 3). For men, being classified within the obese BMI 
range was associated with a significantly lower EQ-5Dindex score (model A). There 
was also an increasingly negative relationship between EQ-5Dindex score and age 
group.  For women, having a BMI which was higher than the desirable BMI range 
had a significant negative effect on EQ-5Dindex score (model C). As for men there was 
also an increasing effect with increasing age.  The model for women was re-
estimated with BMI as a 5 category variable (model D).  This model showed that 
women with a BMI both above and below the desirable range had significantly 
decreased EQ-5Dindex scores, and there was an increasingly negative effect with  





Number of long-standing illnesses was also added to the model along with BMI and 
age group.  For men (model B), the presence of a long-standing illness had a large 
negative effect on EQ-5Dindex score.  However, men who were classified within the 
obese BMI range no longer had significantly lower scores than men with a lower BMI.  
  
For women (model E), although the presence of long-standing illness had a similarly 
significant effect on EQ-5Dindex score, being classified within the overweight or obese 
BMI ranges still had a significantly negative effect on women’s EQ-5Dindex scores.  As 
before, the model for women was re-estimated with BMI as a 5 category variable 
(model F).  The same pattern remained i.e. being classified to anything other than the 
desirable BMI range had a small but significant negative impact on women’s EQ-
5Dindex scores, independent of age and the presence of long-standing illness and this 
relationship was increasingly negative with increasing body weight.   
 
Interactions between BMI and age group and number of long-standing illnesses were 
explored.  None improved the overall goodness of fit of the model and as such are 
not reported here. 
 
Table 3: Modelling the relationship between BMI category and EQ-5Dindex score. 
 
  Men Model  
A 
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26-30kg/m
2 0.002  Ns 0.005  Ns  -0.02 <0.001      -0.01  <0.05     
>30kg/m













2          Base       Base   
26-30 kg/m
2          -0.02  <0.001     -0.02  <0.01 
31-39 kg/m
2          -0.06  <0.001     -0.04  <0.001 
>39 kg/m













   
25-34  yrs  0.0001 Ns 0.0005 Ns 0.0009 Ns 0.0008 Ns 0.0006 Ns 0.0005 Ns 
35-44 yrs  -0.01  Ns  0.001  Ns  -0.02  <0.05 -0.03 <0.05 -0.01 Ns -0.01 Ns 
45-54 yrs  -0.05  <0.05  -0.02  <0.05  -0.04 <0.001 -0.05 <0.001  -0.02 <0.05 -0.02 <0.05 
55-64 yrs  -0.114  <0.001  -0.05  <0.001 -0.106 <0.001 -0.108 <0.001 -0.04 <0.001 -0.04 <0.001 
65-74 yrs  -0.110  <0.001  -0.03  <0.05  -0.117 <0.001 -0.119 <0.001 -0.04 <0.001 -0.04 <0.001 


















1     -0.117  <0.001      -0.115 <0.001 -0.115 <0.001 
2       -0.193  <0.001      -0.196 <0.001 -0.196 <0.001 
3       -0.313  <0.001      -0.283 <0.001 -0.284 <0.001 
4 or more      -0.444  <0.001      -0.428 <0.001 -0.427 <0.001 
Constant  0.915 <0.001  0.948  <0.001 0.910 <0.001 0.916 <0.001 0.946 <0.001 0.951 <0.001 
Adj R






3.4  Multivariate analysis of the relationship between BMI and 
EQ-5D dimension 
The relationship between BMI and each EQ-5D dimension simultaneously was 
explored for men and women separately using MANOVA.  Based on the results from 
the previous models, BMI was defined as a three category variable for men and a 
five category variable for women.   
 
Analysis for men (table 4) revealed that BMI had a small but significant effect on the 
dependent variables (controlling for age and number of comorbidities).  BMI 
accounted for 0.3% of the variance in the dependent variables (partial η
2=0.003).  
Post hoc tests showed that men who were classified to the obese BMI range were 
more likely than other men to report problems on the mobility, self-care, usual 
activities and pain/discomfort dimensions.  Men with a BMI in the overweight range 
reported significantly more problems on the mobility and pain dimensions than men 
in the desirable range.  The likelihood of reporting problems on the 
anxiety/depression dimension was not associated with BMI.  
 
 
Table 4:  MANOVA of relationship between BMI and each EQ-5D dimension 
simultaneously for men and women   
 
  F
a  Sig.   Partial η
2 
Men     
BMI  3.58 <0.001  0.003 
Number of long-standing illnesses 60.53 <0.001  0.06 
Age group  13.6  <0.001  0.01 
Intercept 352.73  <0.001  0.24 
Women     
BMI  7.86 <0.001  0.006 
Number of long-standing illnesses   64.43  <0.001  0.06 
Age group  17.32  <0.001  0.02 
Intercept 467.35  <0.001  0.27 
a  Wilks’ λ 
 
For women, BMI accounted for 0.6% (partial η
2=0.006) of the variance in the 
dependent variables after controlling for age and comorbidities (table 4).  Post hoc 
tests showed that women with a BMI which was either higher or lower than the 
desirable range were more likely to report problems on the self-care dimension, and 
women with a BMI within the overweight and obese ranges were at increased risk of 
reporting problems on the mobility, self-care and usual activities dimensions.   
Women who were classified within the underweight BMI range were the only group at 
increased risk of reporting more problems on the anxiety/depression dimension.  







This study reports on the relationship between BMI and health-related quality of life 
as measured by EQ-5D within a national population sample.  Results revealed 
significant differences in EQ-5D according to BMI category, the nature of which 
differed according to gender and long-standing illness.  
 
Significant differences in the EQ-5D weighted index score could be observed 
according to BMI category for women but not men.  Amongst women, being 
categorised within anything other than the desirable BMI range (i.e. <21kg/m
2  or 
>25kg/m
2) was associated with significantly lower EQ-5Dindex scores, which remained 
after controlling for age and long-standing illness.  For men, being classified within 
the obese BMI range was associated with significantly lower EQ-5Dindex scores, 
although this relationship was not significant after accounting for long-standing 
illness.  Men who were classified within the underweight or overweight BMI ranges 
did not appear to experience any worse health than men who were classified as a 
desirable weight.  
 
Examination of the relationship between BMI category and the five EQ-5D 
dimensions showed that there was a significant increase in the proportion of 
individuals reporting problems on each dimension as BMI moved either above or 
below desirable weight.  The exception was the anxiety/depression dimension, which 
showed little association with BMI.  Controlling for age and long-standing illness 
revealed that men who were classified within the obese BMI range were more likely 
than men with a lower BMI to report problems on all the dimensions except 
anxiety/depression, while men who were classified within the overweight range were 
more likely than men within the desirable BMI range to report problems on the 
mobility and pain dimensions.   For women, there was an increasing association 
between BMI and likelihood of reporting problems across all the EQ-5D dimensions 
(except anxiety/depression) even after controlling for age and long-standing illness.      
 
There was no evidence of a link between overweight and poor psychological health 
as measured by the EQ-5D anxiety/depression dimension. Men and women who 
were classified as overweight or obese were no more likely to report problems on this 
dimension than men or women in the desirable BMI range.  However, women who 
were classified as underweight were more likely to report problems with 
anxiety/depression than women with a higher BMI.  The results are consistent with 
other reports [23] that suggest that the health burden in obesity is primarily physical 
in nature and tends to be experienced in terms of problems with pain and restricted 
mobility along with associated problems in functioning and daily activities.  
 
There is a considerable literature to indicate that women attribute more importance to 
their bodyweight than men and that weight is more closely associated to self-esteem 
in women than men  [e.g. 19, 29, 30, 34].  The findings presented here also suggest 
that women are more likely than men to experience poorer health if they deviate from 
what is considered a desirable weight, independent of age or presence of long-
standing illness.  Gender differences in the relationship between BMI and functional 
limitation have also been reported elsewhere [35].  The underlying mechanism 
behind the gender discrepancy observed here is unclear.  One interpretation is that 
negative attitudes about their weight may bias women’s perceptions or reports of 
their health.  Another possibility is that the poor health observed for women in these 
BMI categories represents future disease which has not yet been diagnosed or 





report symptoms than men, or possibly more at risk of developing symptoms than 
men with a similar BMI.  However, it should also be noted that although significant, 
the relationship between BMI and EQ-5D for both men and women was very small 
compared to the relationship between EQ-5D and both long-standing illness and age.  
 
Two advantages of the Health Survey for England data presented here are the large 
sample size and the fact that the height and weight data were collected by trained 
nurses, rather than relying on self report, which is known to be prone to bias [36].  
Two disadvantages are the cross-sectional nature of the data, which limits any 
conclusions about the causal nature of the results, and the fact that the dataset does 
not include the EQ-5D visual analogue scale. EQ-5Dvas has been shown to 
discriminate between individuals with respect to their self-reported health, self-
reported illness and socio-demographic status as well as, if not better than, other 
measures [37].  Unfortunately it is often omitted by researchers.   
 
Most studies of the relationship between BMI and health-related quality of life have 
not analysed data for men and women separately.  However, these findings suggest 
that BMI relates to HRQoL differently according to gender.  A recent review of the 
effectiveness of obesity treatment [38] also suggests that it may be necessary for 
clinical trials to stratify their results according to gender.  Further investigation of the 
nature of the gender differences in the relationship between BMI and health-related 
quality of life would be useful. 
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